Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial

NCT05803538 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
391
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Dilla University